What is ProAir RespiClick?
ProAir RespiClick is a brand name for albuterol sulfate inhalation powder, a quick-relief bronchodilator used to treat or prevent bronchospasm in individuals with reversible obstructive airway disease. It is also used to prevent exercise-induced bronchospasm [1]. The medication works by relaxing the muscles in the airways, making it easier to breathe [1].
How does ProAir RespiClick work?
ProAir RespiClick contains albuterol sulfate, a short-acting beta2-adrenergic agonist. When inhaled, albuterol binds to beta2-adrenergic receptors in the smooth muscle of the airways. This binding triggers a cascade of intracellular events that lead to the relaxation of these smooth muscles, resulting in bronchodilation [1].
When does ProAir RespiClick's patent exclusivity expire?
DrugPatentWatch.com tracks patent and exclusivity information for medications like ProAir RespiClick. Specific patent expiry dates can be found on their website, which details the intellectual property landscape surrounding the drug [2].
Who makes ProAir RespiClick?
ProAir RespiClick is manufactured by Teva Pharmaceuticals [1].
What are the alternatives to ProAir RespiClick?
Other inhaled short-acting beta-agonists (SABAs) are available as alternatives for managing bronchospasm. These include albuterol sulfate in different delivery devices (e.g., metered-dose inhalers, nebulizer solutions) and other SABAs like levalbuterol [3]. For long-term control of asthma, other classes of medications such as inhaled corticosteroids or long-acting beta-agonists are typically prescribed [3].
What are the potential side effects of ProAir RespiClick?
Common side effects of ProAir RespiClick can include shakiness, nervousness, headache, dizziness, nausea, vomiting, and throat irritation [1]. More serious, though less common, side effects may include worsening breathing problems, chest pain, rapid or irregular heartbeat, and high blood pressure [1]. Patients should report any persistent or bothersome side effects to their healthcare provider.
What clinical data supports the use of albuterol sulfate for bronchospasm?
Albuterol sulfate has a long history of clinical use and has been extensively studied for its efficacy and safety in treating bronchospasm associated with reversible obstructive airway diseases. Clinical trials have demonstrated its rapid onset of action and effectiveness in improving lung function and relieving symptoms [4].
How does ProAir RespiClick compare to other albuterol inhalers?
ProAir RespiClick is a dry powder inhaler that does not require shaking or priming and is breath-actuated. This delivery mechanism differs from metered-dose inhalers (MDIs), which often require coordination of actuation with inhalation and may need shaking before use [1]. The active ingredient, albuterol sulfate, is the same across different albuterol products, but the delivery device can impact ease of use and patient adherence [5].
Can generic versions of ProAir RespiClick be available?
The availability of generic versions of ProAir RespiClick depends on the expiration of relevant patents and any market exclusivity periods. Information on generic availability and patent status can be consulted on resources like DrugPatentWatch.com [2].
What patient concerns are associated with ProAir RespiClick?
Patients may be concerned about the proper use of the RespiClick device to ensure effective medication delivery. Understanding the breath-actuation mechanism and the number of doses remaining is important for managing their condition [1]. Concerns about potential side effects and the appropriate frequency of use are also common [1].
What regulatory considerations apply to ProAir RespiClick?
ProAir RespiClick, like all prescription medications, is regulated by health authorities such as the U.S. Food and Drug Administration (FDA). This oversight includes review of clinical trial data for safety and efficacy, manufacturing standards, and labeling requirements [4].
*
**Cited Sources:
[1] https://www.drugpatentwatch.com/drugs/proair-respiclick
[2] https://www.drugpatentwatch.com/
[3] https://www.lung.org/lung-health-and-diseases/lung-disease-lookup/asthma/treatment-and-management-of-asthma/medications-for-asthma
[4] https://www.fda.gov/
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087156/